AD Roth
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Medical Education and Admissions 2
- Innovations in Medical Education 1
- Health and Medical Research Impacts 1
- Oncology 1
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- May Klink Alakl (1 shared paper)Pavel Jandík (1 shared paper)Matilde Navarro (1 shared paper)J Carmichael (1 shared paper)Petr Karásek (1 shared paper)J-Y Douillard (1 shared paper)Timothy J. Iveson (1 shared paper)G. Gruia (1 shared paper)
- Journals
- The Lancet (1 paper)Swiss Medical Weekly (1 paper)UCL Discovery (University College London) (2 papers)
- Partner nations
- SpainCzechiaSwitzerland
In The Last Decade
AD Roth
4 papers receiving 2.6k citations
AD Roth's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 2k
- Pharmacology 139
- Hepatology 84
- Molecular Biology 359
- Geriatrics and Gerontology 18
Countries citing papers authored by AD Roth
This map shows the geographic impact of AD Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AD Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AD Roth more than expected).
Fields of papers citing papers by AD Roth
This network shows the impact of papers produced by AD Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AD Roth. The network helps show where AD Roth may publish in the future.
Co-authors
The 15 scholars most cited alongside AD Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial Hit paper breakdown → | 2000 | 2717 |
| 2 | 2011 | 6 | |
| 3 | Selecting for clinical training | 1995 | 4 |
| 4 | Getting on clinical training courses | 1998 | 3 |
About AD Roth
AD Roth is a scholar working on Public Health, Environmental and Occupational Health, Oncology, Pulmonary and Respiratory Medicine, Nuclear Energy and Engineering and Waste Management and Disposal, having authored 4 papers that have together received 2.7k indexed citations. Recurring topics across this work include Medical Education and Admissions (2 papers), Colorectal Cancer Treatments and Studies (1 paper), Innovations in Medical Education (1 paper), Gastric Cancer Management and Outcomes (1 paper) and Health and Medical Research Impacts (1 paper). The work is most often cited by research in Oncology (2k citations), Pharmacology (139 citations), Hepatology (84 citations), Molecular Biology (359 citations) and Geriatrics and Gerontology (18 citations). AD Roth has collaborated with scholars based in Spain, Czechia and Switzerland. Frequent co-authors include May Klink Alakl, Pavel Jandík, Matilde Navarro, J Carmichael, Petr Karásek, J-Y Douillard, Timothy J. Iveson, G. Gruia, David Cunningham and Philippe R Rougier. Their work appears in journals such as The Lancet, Swiss Medical Weekly and UCL Discovery (University College London).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.